Natco Pharma declares ₹1.50 interim dividend for FY25-26; Record Date: Nov 20, 2025
Natco Pharma declared an interim dividend of ₹1.50 per share for FY25-26. The record date is November 20, 2025, with payments starting November 28, 2025.
The declaration of an interim dividend provides a direct financial benefit to shareholders, indicating a stable financial position, hence a medium positive impact.
The company declared an interim dividend of ₹1.50 per equity share, which is a positive return for shareholders.
* The Board of Directors of Natco Pharma Limited, at their meeting held on November 14, 2025, declared an interim dividend of ₹1.50 (75%) per equity share of ₹2 each for the financial year 2025-26. The record date for determining shareholders eligible for the interim dividend has been fixed as Thursday, November 20, 2025. The payment of the said interim dividend will commence from November 28, 2025.
What to do with a filing like this
Natco Pharma Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Natco Pharma Limited. Read the original for the full detail.